Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 31 Jul 24 RW Registration withdrawal request
- 29 Sep 23 S-1/A IPO registration (amended)
- 6 Sep 23 S-1/A IPO registration (amended)
- 7 Jul 23 S-1/A IPO registration (amended)
-
26 Jan 23 S-1/A IPO registration (amended)
- 4 Jan 23 S-1/A IPO registration (amended)
- 27 Sep 22 S-1/A IPO registration (amended)
- 16 Aug 22 S-1 IPO registration
EMTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1/A of our report dated May 6, 2022, with respect to the audited consolidated financial statements of EMulate Therapeutics, Inc. for the years ended December 31, 2021, and 2020. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP | |
www.malonebailey.com | |
Houston, Texas | |
January 25, 2023 |